Personalis, Inc. (NASDAQ PSNL) is a clinical genomics and cancer diagnostics company based in Fremont, California. It develops advanced tumor and immune profiling tests built on next-generation sequencing, including its NeXT Personal ultra-sensitive tumor-informed molecular residual disease (MRD) and recurrence-monitoring assay and the ImmunoID… - View it on GitHub